In today's Health Alert, we learn about new FDA approved treatment and the importance of early detection of breast cancer.

The FDA has approved the first treatment that genetically engineers patients' own blood cells to seek and destroy childhood leukemia.

The breakthrough CAR-T cell treatment is for children and young adults with acute lymphoblastic leukemia, or all, who have relapsed despite today's best treatments.

Even with some serious side effects, a key test found a one-time infusion put about 80 percent of hard-to-treat patients into remission.

And it's the 9th of the month. Don't forget to call your buddies and remind them about the importance of early detection in the fight against breast cancer.

Underscoring this point, British scientists have found that breast cancer cells that spread to other parts of the body, break off and leave the primary tumor at late stages of disease development.

The results show that catching and treating breast cancer before it spreads is a realistic goal. It also opens the door to predicting which drugs will work against breast cancer that has already spread.